Anterior vs Humata Health

What it does

• AI clinical reasoning against payer medical policies
• Prior authorization review with nurse-in-the-loop workflow
• Auto-approval of clean requests, flagging of edge cases
• Embedded clinicians who tune accuracy in production
• Audit trails for every determination
• Five-day average deployment into plan workflows

Where it's strong

• Clinical accuracy of 99.24% in live production was independently validated by KLAS Research.
• Founded and staffed by clinicians, which helps with medical director buy-in inside plans.
• Deploys into existing UM workflows in days rather than the multi-month integrations typical of payer software.

What buyers should weigh

• Sells only to payers, so provider organizations looking for a submission-side tool are not the buyer.
• Young company with a small number of named reference customers, so diligence on scale is warranted.
• State laws increasingly require licensed clinicians to make denial decisions, so buyers must define where AI output stops and human judgment starts.

Named customers

Geisinger Health Plan

Integrations

What it does

• Matches payer policies to determine if prior auth is required
• Auto-gathers and bundles clinical documentation for submission
• Submits authorizations touchlessly across payer connections
• Monitors auth status and flags changes after submission
• Detects CPT mismatches before submission
• Supports gold-carding and exception-based review workflows

Where it's strong

• Founder Jeremy Friese, MD previously built and sold Verata Health, so this is a second product in the same category, not a first attempt.
• Strategic investors on the payer side (Blue Venture Fund, Optum Ventures, Highmark Ventures) give it unusual payer connectivity for a provider-facing tool.
• Real deployment scale for its age: roughly 225 hospitals and 42,000 physicians, plus CMS selecting it as a technology partner for the WISeR model.

What buyers should weigh

• Headline metrics like 96% first-pass approval and 45% fewer manual touches are vendor-reported, so validate them against your own service lines in a pilot.
• Its role as an AI clinical-review partner in the CMS WISeR model puts it on both the provider and payer sides of prior auth, which some provider organizations may see as a conflict.
• The company traces back to prior authorization assets from Olive AI, which shut down, so diligence which parts of the platform are new versus inherited.

Named customers

Texas Health Resources · Hartford HealthCare · Renown Health · Rochester Regional Health · Lee Health

Integrations